Vaxart Suit Turns 'Mundane To Nefarious,' Del. Judge Told

By Jon Hill · July 28, 2021, 9:59 PM EDT

Counsel for top brass of biotech firm Vaxart Inc. pushed at a Delaware Chancery Court hearing Wednesday for dismissal of a derivative suit alleging that company insiders profiteered off news about...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Jon

June 11, 2024
CFPB Floats Rule To Take Medical Debt Off Credit Reports
September 21, 2023
CFPB Plans Take Aim At Medical Debt Reporting, Data Brokers
July 07, 2023
CFPB-Backed Joint Inquiry Eyes Medical Credit Cards, Loans
June 08, 2023
CFPB Levies First Medical Debt Collector Fine Under Chopra
March 01, 2022
CFPB Chief Warns Of 'Weaponized' Medical Debt Reporting
August 06, 2020
Feds Charge 9 With $24M Virus Relief Loans Fraud Scheme
August 07, 2018
JP Morgan Can't Duck FINRA Arbitration, 3rd Circ. Says
March 20, 2018
Wells Fargo Reaches Confidential Deal Resolving ERISA Suit
March 12, 2018
Magellan Health Ducks Investor Suit Over AlphaCare Merger
February 22, 2018
4th Circ. Resurrects Medical Device Co. Investor Suit